🎗️ OncologyInjection (IV)
Elzonris
Tagraxofusp
CD123-directed cytotoxin for treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Elzonris used for?
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
02
Tagraxofusp side effects
The following side effects have been reported for Tagraxofusp. Their order does not indicate how often an effect occurs.
Capillary leak syndrome
Nausea
Fatigue
Peripheral edema
Hypoalbuminemia
03
Tagraxofusp warnings & precautions
- Black box: capillary leak syndrome. May be fatal, monitor albumin daily
- Premedication required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Elzonris in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.